Apoptotic mediators in patients with severe and non-severe dengue from Brazil

Journal of Medical Virology

Volumn 86, Issue 8, 2014, Pages 1437-1447

  Limonta, Daniel ^a   Torrentes Carvalho, Amanda ^a   Marinho, Cíntia Ferreira ^a   de Azeredo, Elzinandes Leal ^a   de Souza, Luiz José ^b   Motta Castro, Ana Rita C ^c   da Cunha, Rivaldo Venâncio ^c   Kubelka, Claire Fernandes ^a   Nogueira, Rita Maria Ribeiro ^a   de Oliveira Pinto, Luzia Maria ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Centro Regional de Referência em Dengue Campos dos Goytacazes   (Brazil)

^c FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Apoptosis; Lymphocytes; Monocytes; Pathogenesis

Indexed keywords

FAS LIGAND; INHIBITOR OF APOPTOSIS PROTEIN; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS; APOPTOSIS REGULATORY PROTEIN;

ADULT; APOPTOSIS; ARTICLE; BLOOD CELL; BLOOD LEVEL; BRAZIL; CD8+ T LYMPHOCYTE; CELL LYSATE; CELL PROTECTION; CONTROLLED STUDY; DENGUE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; MONOCYTE; PATHOGENESIS; PATIENT CODING; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; BLOOD; CHEMISTRY; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; YOUNG ADULT;

ADULT; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BRAZIL; DENGUE; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PLASMA; YOUNG ADULT;

EID: 84901834255     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23832     Document Type: Article

References (68)

1. Alexander N, Balmaseda A, Coelho IC, Dimaano E, Hien TT, Hung NT, Janisch T, Kroeger A, Lum LC, Martinez E, Siqueira JB, Thuy TT, Villalobos I, Villegas E, Wills B. 2011. Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health 16:936-948.
2. Altieri DC. 2010. Survivin and IAP proteins in cell-death mechanisms. Biochem J 430:199-205.
3. Azizan A, Sweat J, Espino C, Gemmer J, Stark L, Kazanis D. 2006. Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus. J Virol Methods 138:211-217.
4. Balas C, Kennel A, Deauvieau F, Sodoyer R, Arnaud-Barbe N, Lang J, Guy B. 2011. Different innate signatures induced in human monocyte-derived dendritic cells by wild-type dengue 3 virus, attenuated but reactogenic dengue 3 vaccine virus, or attenuated nonreactogenic dengue 1-4 vaccine virus strains. J Infect Dis 203:103-108.
5. Balmaseda A, Hammond SN, Perez L, Tellez Y, Saborio SI, Mercado JC, Cuadra R, Rocha J, Perez MA, Silva S, Rocha C, Harris E. 2006. Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 74:449-456.
6. Barniol J, Gaczkowski R, Barbato EV, da Cunha RV, Salgado D, Martinez E, Segarra CS, Pleites Sandoval EB, Mishra A, Laksono IS, Lum LC, Martinez JG, Nunez A, Balsameda A, Allende I, Ramirez G, Dimaano E, Thomacheck K, Akbar NA, Ooi EE, Villegas E, Hien TT, Farrar J, Horstick O, Kroeger A, Jaenisch T. 2011. Usefulness and applicability of the revised dengue case classification by disease: Multi-centre study in 18 countries. BMC Infect Dis 11:106.
7. Becerra A, Warke RV, Martin K, Xhaja K, de Bosch N, Rothman AL, Bosch I. 2009. Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo. J Med Virol 81:1403-1411.
8. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. 2013. The global distribution and burden of dengue. Nature 496:504-507.
9. Bokarewa M, Tarkowski A, Magnusson M. 2007. Pathological survivin expression links viral infections with pathogenesis of erosive rheumatoid arthritis. Scand J Immunol 66:192-198.
10. Borges Bdo N, Burbano RR, Harada ML. 2011. Survivin -31C/G polymorphism and gastric cancer risk in a Brazilian population. Clin Exp Med 11:189-193.
11. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, Bozza PT, Kubelka CF. 2008. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8:86.
12. Braga EL, Moura P, Pinto LM, Ignacio SR, Oliveira MJ, Cordeiro MT, Kubelka CF. 2001. Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Mem Inst Oswaldo Cruz 96:229-232.
13. Cardier JE, Marino E, Romano E, Taylor P, Liprandi F, Bosch N, Rothman AL. 2005. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: Possible role of TNF-alpha in endothelial cell damage in dengue. Cytokine 30:359-365.
14. Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM. 2006. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 74:142-147.
15. Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA. 2007. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 81:5518-5526.
16. Crist SA, Elzey BD, Ludwig AT, Griffith TS, Staack JB, Lentz SR, Ratliff TL. 2004. Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets. Exp Hematol 32:1073-1081.
17. Cummins NW, Badley AD. 2010. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis 1:e99.
18. de-Oliveira-Pinto LM, Marinho CF, Povoa TF, de Azeredo EL, de Souza LA, Barbosa LD, Motta-Castro AR, Alves AM, Avila CA, de Souza LJ, da Cunha RV, Damasco PV, Paes MV, Kubelka CF. 2012. Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever. PLoS ONE 7:e38527.
19. Fernandez-Mestre MT, Gendzekhadze K, Rivas-Vetencourt P, Layrisse Z. 2004. TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64:469-472.
20. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nunez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G. 2012. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19:107-120.
21. Gandini M, Gras C, Azeredo EL, Pinto LM, Smith N, Despres P, da Cunha RV, de Souza LJ, Kubelka CF, Herbeuval JP. 2013. Dengue virus activates membrane TRAIL relocalization and IFN-alpha production by human plasmacytoid dendritic cells in vitro and in vivo. PLoS Negl Trop Dis 7:e2257.
22. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW. 2010. Dengue: A continuing global threat. Nat Rev Microbiol 8:S7-S16.
23. Hensley LE, Young HA, Jahrling PB, Geisbert TW. 2002. Proinflammatory response during Ebola virus infection of primate models: Possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 80:169-179.
24. Hoang LT, Lynn DJ, Henn M, Birren BW, Lennon NJ, Le PT, Duong KT, Nguyen TT, Mai LN, Farrar JJ, Hibberd ML, Simmons CP. 2010. The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol 84:12982-12994.
25. Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, Imbert P, Pecarere JL, Vergez-Pascal R, Wattre P, Maniez-Montreuil M. 1993. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 48:324-331.
26. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. 2009. Cell death. N Engl J Med 361:1570-1583.
27. Huerre MR, Lan NT, Marianneau P, Hue NB, Khun H, Hung NT, Khen NT, Drouet MT, Huong VT, Ha DQ, Buisson Y, Deubel V. 2001. Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch 438:107-115.
28. Igarashi A. 1978. Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. J Gen Virol 40:531-544.
29. Jaiyen Y, Masrinoul P, Kalayanarooj S, Pulmanausahakul R, Ubol S. 2009. Characteristics of dengue virus-infected peripheral blood mononuclear cell death that correlates with the severity of illness. Microbiol Immunol 53:442-450.
30. Kadhiravan T, Saxena A, Singh A, Broor S, Sharma SK, Mitra DK. 2010. Association of intracellular T(H)1-T(H)2 balance in CD4+ T-cells and MIP-1alpha in CD8+ T-cells with disease severity in adults with dengue. Immune Netw 10:164-172.
31. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40:444-451.
32. Korner C, Riesner K, Kramer B, Eisenhardt M, Glassner A, Wolter F, Berg T, Muller T, Sauerbruch T, Nattermann J, Spengler U, Nischalke HD. 2012. TRAIL receptor I (DR4) polymorphisms C626G und A638C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients. BMC Cancer 12:85.
33. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30:545-551.
34. Laur F, Murgue B, Deparis X, Roche C, Cassar O, Chungue E. 1998. Plasma levels of tumour necrosis factor alpha and transforming growth factor beta-1 in children with dengue 2 virus infection in French Polynesia. Trans R Soc Trop Med Hyg 92:654-656.
35. Law HK, Cheung CY, Sia SF, Chan YO, Peiris JS, Lau YL. 2009. Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells. BMC Immunol 10:35.
36. Levy A, Valero N, Espina LM, Anez G, Arias J, Mosquera J. 2010. Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue. Trans R Soc Trop Med Hyg 104:16-23.
37. Liao H, Xu J, Huang J. 2010. FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells. J Med Virol 82:1392-1399.
38. Liew KJ, Chow VT. 2006. Microarray and real-time RT-PCR analyses of a novel set of differentially expressed human genes in ECV304 endothelial-like cells infected with dengue virus type 2. J Virol Methods 131:47-57.
39. Limjindaporn T, Netsawang J, Noisakran S, Thiemmeca S, Wongwiwat W, Sudsaward S, Avirutnan P, Puttikhunt C, Kasinrerk W, Sriburi R, Sittisombut N, Yenchitsomanus PT, Malasit P. 2007. Sensitization to Fas-mediated apoptosis by dengue virus capsid protein. Biochem Biophys Res Commun 362:334-339.
40. Limonta D, Capo V, Torres G, Perez AB, Guzman MG. 2007. Apoptosis in tissues from fatal dengue shock syndrome. J Clin Virol 40:50-54.
41. Limonta D, Gonzalez D, Capo V, Torres G, Perez AB, Rosario D, Roche-Rodriguez R, Alvarez M, Guzman MG. 2009. Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic. Int J Infect Dis 13:e77-e78.
42. Locksley RM, Killeen N, Lenardo MJ. 2001. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104:487-501.
43. Matsuda T, Almasan A, Tomita M, Tamaki K, Saito M, Tadano M, Yagita H, Ohta T, Mori N. 2005. Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. J Gen Virol 86:1055-1065. Retraction in: J Gen Virol 2010 Oct; 1091: 2658.
44. Melloni E, Secchiero P, Celeghini C, Campioni D, Grill V, Guidotti L, Zauli G. 2005. Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development. J Cell Physiol 204:975-982.
45. Mera S, Magnusson M, Tarkowski A, Bokarewa M. 2008. Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern. J Leukoc Biol 83:149-155.
46. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9:921-927.
47. Myint KS, Endy TP, Mongkolsirichaikul D, Manomuth C, Kalayanarooj S, Vaughn DW, Nisalak A, Green S, Rothman AL, Ennis FA, Libraty DH. 2006. Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis. J Infect Dis 194:600-607.
48. Narvaez F, Gutierrez G, Perez MA, Elizondo D, Nunez A, Balmaseda A, Harris E. 2011. Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl Trop Dis 5:e1397.
49. Nasi M, Pinti M, Bugarini R, Troiano L, Lugli E, Bellodi C, Mussini C, Borghi V, Trenti T, Balli F, Esposito R, Cossarizza A. 2005. Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naive HIV-positive patients. Immunogenetics 57:628-635.
50. Okada H, Kobune F, Sato TA, Kohama T, Takeuchi Y, Abe T, Takayama N, Tsuchiya T, Tashiro M. 2000. Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol 145:905-920.
51. Perez AB, Sierra B, Garcia G, Aguirre E, Babel N, Alvarez M, Sanchez L, Valdes L, Volk HD, Guzman MG. 2010. Tumor necrosis factor-alpha, transforming growth factor-beta1, and interleukin-10 gene polymorphisms: Implication in protection or susceptibility to dengue hemorrhagic fever. Hum Immunol 71:1135-1140.
52. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, Patwardhan S, Mokashi N, Vaidya D, Shah PS, Cecilia D. 2010. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: A facility-based study. PLoS ONE 5:e8709.
53. Roe MF, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O'Donnell DR. 2004. Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol 137:139-145.
54. Rothman AL. 2010. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr Top Microbiol Immunol 338:83-98.
55. Shrestha B, Pinto AK, Green S, Bosch I, Diamond MS. 2012. CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons. J Virol 86:8937-8948.
56. Sierra B, Alegre R, Perez AB, Garcia G, Sturn-Ramirez K, Obasanjo O, Aguirre E, Alvarez M, Rodriguez-Roche R, Valdes L, Kanki P, Guzman MG. 2007. HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: Advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol 68:531-540.
57. Silke J, Meier P. 2013. Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. Cold Spring Harb Perspect Biol 5.
58. Simmons CP, Farrar JJ, Nguyen VV, Wills B. 2012. Dengue. N Engl J Med 366:1423-1432.
59. Song J, So T, Cheng M, Tang X, Croft M. 2005. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 22:621-631.
60. Suksanpaisan L, Cabrera-Hernandez A, Smith DR. 2007. Infection of human primary hepatocytes with dengue virus serotype 2. J Med Virol 79:300-307.
61. Torrentes-Carvalho A, Azeredo EL, Reis SR, Miranda AS, Gandini M, Barbosa LS, Kubelka CF. 2009. Dengue-2 infection and the induction of apoptosis in human primary monocytes. Mem Inst Oswaldo Cruz 104:1091-1099.
62. Vejbaesya S, Luangtrakool P, Luangtrakool K, Kalayanarooj S, Vaughn DW, Endy TP, Mammen MP, Green S, Libraty DH, Ennis FA, Rothman AL, Stephens HA. 2009. TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis 199:1442-1448.
63. Warke RV, Becerra A, Zawadzka A, Schmidt DJ, Martin KJ, Giaya K, Dinsmore JH, Woda M, Hendricks G, Levine T, Rothman AL, Bosch I. 2008a. Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells. J Gen Virol 89:1605-1615.
64. Warke RV, Martin KJ, Giaya K, Shaw SK, Rothman AL, Bosch I. 2008b. TRAIL is a novel antiviral protein against dengue virus. J Virol 82:555-564.
65. World Health Organization. 2009. Dengue: Guidelines for diagnosis, treatment, prevention and control. Geneva: WHO Press.
66. Wong KL, Chen W, Balakrishnan T, Toh YX, Fink K, Wong SC. 2012. Susceptibility and response of human blood monocyte subsets to primary dengue virus infection. PLoS ONE 7:e36435.
67. Zauli G, Secchiero P. 2006. The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. Cytokine Growth Factor Rev 17:245-257.
68. Zhu Y, Roshal M, Li F, Blackett J, Planelles V. 2003. Upregulation of survivin by HIV-1 Vpr. Apoptosis 8:71-79.